Postoperative chemotherapy in nonsmall cell lung cancer: a systematic review.

  • Alam N
  • Darling G
  • Shepherd F
 et al. 
  • 10


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


A systematic review of the evidence for postoperative chemotherapy in completely resected nonsmall cell lung cancer was conducted. Seven meta-analyses and 25 randomized trials met the pre-defined eligibility criteria for the review. The evidence indicates that postoperative platinum-based chemotherapy improves survival compared with surgery alone; for patients with a good performance status who are fit enough for chemotherapy, the survival benefits strongly outweigh the adverse effects of treatment. To date the trials restricted to stage IB or II disease have obtained the greatest survival benefits with postoperative platinum-based chemotherapy. The evidence does not support the use of postoperative radiotherapy with chemotherapy.

Author-supplied keywords

  • Adenocarcinoma
  • Adenocarcinoma: drug therapy
  • Adenocarcinoma: mortality
  • Adenocarcinoma: surgery
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Non-Small-Cell Lung: drug therapy
  • Carcinoma, Non-Small-Cell Lung: mortality
  • Carcinoma, Non-Small-Cell Lung: surgery
  • Lung Neoplasms
  • Lung Neoplasms: drug therapy
  • Lung Neoplasms: mortality
  • Lung Neoplasms: surgery
  • Meta-Analysis as Topic
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic
  • Receptors, Chemokine
  • Survival Analysis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Naveed Alam

  • Gail Darling

  • Frances a Shepherd

  • Jean a Mackay

  • William K Evans

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free